Subscribe: MedWorm: Radioiodine Therapy
Preview: MedWorm: Radioiodine Therapy

MedWorm: Radioiodine Therapy News provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Radioiodine Therapy

Last Build Date: Fri, 19 Jan 2018 11:42:54 +0100


Radioiodine Therapy for Thyroid Cancer Doesn ’ t Up Stroke Risk

Sat, 19 Aug 2017 00:00:00 +0100

I - 131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke (Source: The Doctors Lounge - Oncology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Surgically Ablated Thyroid Cancer Does Not Need Adjuvant RAISurgically Ablated Thyroid Cancer Does Not Need Adjuvant RAI

Tue, 12 Apr 2016 15:07:44 +0100

In patients with intermediate-risk thyroid cancer that has been surgically ablated, adjuvant radioiodine therapy may not be necessary. Clinical Endocrinology (Source: Medscape Today Headlines)

miR-339-5p modulates NIS-mediated RAIU

Mon, 26 Jan 2015 12:00:00 +0100

Na+/I− symporter (NIS)-mediated radioiodide uptake (RAIU) serves as the basis for targeted ablation of thyroid cancer remnants. However, many thyroid cancer patients have reduced NIS expression/function. microRNAs (miRs) have emerged as a promising therapeutic method; Lakshmanan and colleagues make the first report to demonstrate that hNIS-mediated RAIU can be modulated by miRs, and that the same miRs may also play roles in thyroid malignancy. Accordingly, miRs may serve to halt the progression of thyroid cancer and to enhance the efficacy of radioiodine therapy. Read the full article at Lakshmanan et al. (2015) Endocrine-Related Cancer 22 11–21 DOI:10.1530/ERC-14-0439 (Source: Society for Endocrinology)

New guidance on radioiodine therapy use after radiographic studies

Wed, 01 May 2013 03:15:44 +0100

Researchers have provided new evidence that could act as a guide for the use of radioiodine therapy after patients have undergone radiographic imaging studies that use iodine as a contrasting agent. (Source: MedWire News - Oncology)